Literature DB >> 20091658

Roselle for hypertension in adults.

Chetta Ngamjarus1, Porjai Pattanittum, Charoonsak Somboonporn.   

Abstract

BACKGROUND: Hypertension is considered a serious health problem worldwide. Controlling and lowering blood pressure have a significant benefit to the hypertensive patients because hypertension is a risk factor for stroke, heart disease and cardiovascular disease. A tropical plant called Roselle, or Red Sorrel in English-speaking countries, has been used both as a thirst-quenching drink and for medical purposes.
OBJECTIVES: To explore the effect of Roselle on blood pressure in hypertensive adult patients. SEARCH STRATEGY: The following databases were searched (Date of most recent search was September 2009): - Cochrane Database of Systematic Reviews (2nd Quarter 2009) - DARE (2nd Quarter 2009) - Ovid MEDLINE (1950 to Present with Daily Update) - EMBASE (1980 to 2009 Week 22) - AMED (1985 to May 2009) - EBSCO CINAHL - BIOSIS (1969 to 2008) - AGRICOLA (1970 to May 2009) - Food Science and Technology Abstract (1969 to 2009 June Week 1) - International Pharmaceutical Abstracts - International Bibliographic Information on Dietary Supplements - Clinical Trials.gov and Current Controlled Trials - OpenSIGLE - Hand searching of journals - ISI Web of Knowledge SELECTION CRITERIA: We sought randomised control trials (RCTs) evaluating use of any forms of Roselle with placebo or no treatment in hypertensive patients. Change in trough and/or peak systolic and diastolic blood pressure were primary outcomes. Secondary outcomes were withdrawals due to adverse effects, change of pulse pressure and change of heart rate. DATA COLLECTION AND ANALYSIS: Two review authors (C Ngamjarus, CN and P Pattanittum, PP) independently scanned titles and abstracts, as well as independently screened the full reports of the potentially relevant studies. At each stage, the results were compared and disagreements were solved by discussion. MAIN
RESULTS: No studies were identified that met the inclusion criteria. However, one abstract of an ongoing study is likely to meet the inclusion criteria, when completed. AUTHORS'
CONCLUSIONS: There is insufficient evidence to support the benefit of Roselle for either controlling or lowering blood pressure in patients with hypertension. Based on the information of this review, there is a clear need to develop well-designed studies to assess the efficacy of Roselle on hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091658      PMCID: PMC7182310          DOI: 10.1002/14651858.CD007894.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  14 in total

Review 1.  Selected major risk factors and global and regional burden of disease.

Authors:  Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

2.  Complementary/alternative medicine for hypertension: a mini-review.

Authors:  Edzard Ernst
Journal:  Wien Med Wochenschr       Date:  2005-09

3.  The effect of sour tea (Hibiscus sabdariffa) on essential hypertension.

Authors:  M Haji Faraji; A Haji Tarkhani
Journal:  J Ethnopharmacol       Date:  1999-06       Impact factor: 4.360

4.  Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial.

Authors:  Armando Herrera-Arellano; Judith Miranda-Sánchez; Pedro Avila-Castro; Sara Herrera-Alvarez; Jesús Enrique Jiménez-Ferrer; Alejandro Zamilpa; Rubén Román-Ramos; Héctor Ponce-Monter; Jaime Tortoriello
Journal:  Planta Med       Date:  2007-01       Impact factor: 3.352

Review 5.  Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: a review.

Authors:  Badreldin H Ali; Naser Al Wabel; Gerald Blunden
Journal:  Phytother Res       Date:  2005-05       Impact factor: 5.878

6.  Chronic administration of aqueous extract of Hibiscus sabdariffa attenuates hypertension and reverses cardiac hypertrophy in 2K-1C hypertensive rats.

Authors:  I P Odigie; R R Ettarh; S A Adigun
Journal:  J Ethnopharmacol       Date:  2003-06       Impact factor: 4.360

7.  Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial.

Authors:  A Herrera-Arellano; S Flores-Romero; M A Chávez-Soto; J Tortoriello
Journal:  Phytomedicine       Date:  2004-07       Impact factor: 5.340

8.  Antihypertensive effect of an aqueous extract of the calyx of Hibiscus sabdariffa.

Authors:  F B O Mojiminiyi; M Dikko; B Y Muhammad; P D Ojobor; O P Ajagbonna; R U Okolo; U V Igbokwe; U E Mojiminiyi; M A Fagbemi; S O Bello; T J Anga
Journal:  Fitoterapia       Date:  2007-04-11       Impact factor: 2.882

Review 9.  Herbal medicines as diuretics: a review of the scientific evidence.

Authors:  C I Wright; L Van-Buren; C I Kroner; M M G Koning
Journal:  J Ethnopharmacol       Date:  2007-07-31       Impact factor: 4.360

10.  The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes.

Authors:  H Mozaffari-Khosravi; B-A Jalali-Khanabadi; M Afkhami-Ardekani; F Fatehi; M Noori-Shadkam
Journal:  J Hum Hypertens       Date:  2008-08-07       Impact factor: 3.012

View more
  2 in total

Review 1.  Roselle for hypertension in adults.

Authors:  Porjai Pattanittum; Chetta Ngamjarus; Fonthip Buttramee; Charoonsak Somboonporn
Journal:  Cochrane Database Syst Rev       Date:  2021-11-27

Review 2.  Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies.

Authors:  Allison L Hopkins; Marnie G Lamm; Janet L Funk; Cheryl Ritenbaugh
Journal:  Fitoterapia       Date:  2013-01-17       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.